Dense breasts and cancer risk: What women need to know
Spring 2016
“Being diagnosed with cancer and told that it may rule out parenthood can be devastating for people who haven’t yet started or completed their families,” says Terri Woodard, M.D., assistant professor of Gynecologic Oncology and Reproductive Medicine. Woodard directs MD Anderson’s Oncofertility Clinic.
At the Oncofertility Clinic, oncology and reproductive medicine
intersect to help cancer patients preserve fertility before treatment.
MD Anderson surgeons are adopting a program pioneered by their peers in
Europe that makes life easier for patients before, during and after surgery.
A new study is seeking new drugs to combat triple-negative breast
cancer, an aggressive form of the disease that doesn’t rely on the
hormones estrogen and progesterone or the protein HER2, which fuel the
growth of most breast cancers.
As a pediatric cancer clinician and researcher, Patrick Zweidler-McKay
has devoted his career to treating children with particularly difficult
or relapsed forms of cancer.
Thanks to teamwork and quick thinking, valuable cancer research was
saved when wildfires threatened the Smithville campus last October.
An oncologist and a surgeon from different hospitals work together to
treat primary cardiac sarcomas, aka heart tumors.
From the AIDS epidemic to fighting T cell lymphomas and skin cancer,
much of Madeleine Duvic’s work has dealt with these white blood cells.
Physicians and scientists are treating cancer by using their knowledge
of the cellular functions shared by it and other diseases.
Cord blood and half-match options provide patients with a whole lot of hope.
Cancer prevention experts weigh in on how to decrease your risk for
cancer by avoiding carcinogens on a daily basis.
MD Anderson researchers have recently published studies that point to a
connection between cancer and our diets and eating habits.
Cancer immunotherapy leaders at MD Anderson will work with experts at
five other cancer centers in a new alliance funded by the largest single
contribution ever made to the field.
Researchers with MD Anderson’s Colorectal Cancer Moon Shot are
sharpening the focus of a genetic tool designed to classify colorectal
cancer into one of four categories — a vital step toward improving treatment.
Previous Issues
View archives
Fall 2018
Celebrating a breakthrough discovery
Summer 2018
Leaving pain behind and looking ahead to life
Spring 2018
The p53 pioneer
Fall 2017
The hospital's heroes
Summer 2017
A growing area of study
Spring 2017
A dogged pursuit
Fall 2016
Big data, big results
Summer 2016
Building on success
Fall 2015
The cold virus versus cancer
Summer 2015
Empowered Prevention
Spring 2015
No patient left behind
Fall 2014
The cancer vaccine
Summer 2014
The game changer
Spring 2014
Plans to knock out tobacco
Fall 2013
Looking beyond the cancer cell
Summer 2013
A magnificent seven
Spring 2013
Moon shots program update
Fall 2012
MD Anderson's Moon Shots Program
Summer 2012
Where change begins
Spring 2012
The Pilots of the OR
Fall 2011
Changing the Stories We Tell
Summer 2011
Through Whirlwind and Calm
Spring 2011
Lungs That Function Not Taken for Granted
Fall 2010
Branching Out to Conquer Cancer
Summer 2010
Survivorship:
Spring 2010
Pathology: